Trexquant Investment’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.58M | Buy |
+210,428
| New | +$5.58M | 0.06% | 489 |
|
|
2025
Q1 | – | Sell |
-64,908
| Closed | -$2.61M | – | 1896 |
|
|
2024
Q4 | $2.61M | Buy |
+64,908
| New | +$2.61M | 0.03% | 768 |
|
|
2024
Q3 | – | Sell |
-51,296
| Closed | -$2.72M | – | 1890 |
|
|
2024
Q2 | $2.72M | Buy |
+51,296
| New | +$2.72M | 0.04% | 626 |
|
|
2023
Q4 | – | Sell |
-84,147
| Closed | -$932K | – | 1823 |
|
|
2023
Q3 | $932K | Sell |
84,147
-182,172
| -68% | -$2.02M | 0.02% | 781 |
|
|
2023
Q2 | $4.32M | Buy |
266,319
+197,394
| +286% | +$3.2M | 0.11% | 248 |
|
|
2023
Q1 | $1.15M | Sell |
68,925
-41,489
| -38% | -$691K | 0.03% | 682 |
|
|
2022
Q4 | $1.04M | Buy |
+110,414
| New | +$1.04M | 0.03% | 627 |
|
|
2022
Q1 | – | Sell |
-18,714
| Closed | -$86K | – | 1758 |
|
|
2021
Q4 | $86K | Buy |
18,714
+84
| +0.5% | +$386 | 0.01% | 1244 |
|
|
2021
Q3 | $117K | Sell |
18,630
-2,671
| -13% | -$16.8K | 0.01% | 1036 |
|
|
2021
Q2 | $128K | Buy |
+21,301
| New | +$128K | 0.01% | 992 |
|
|
2021
Q1 | – | Sell |
-19,721
| Closed | -$111K | – | 1500 |
|
|
2020
Q4 | $111K | Sell |
19,721
-41,702
| -68% | -$235K | 0.01% | 960 |
|
|
2020
Q3 | $357K | Buy |
+61,423
| New | +$357K | 0.02% | 850 |
|
|
2018
Q2 | – | Sell |
-64,413
| Closed | -$281K | – | 1248 |
|
|
2018
Q1 | $281K | Buy |
+64,413
| New | +$281K | 0.02% | 835 |
|